Rowan Labs and decentralized AI subnet Macrocosmos are teaming up to train novel AI neural networks to accelerate inexpensive drug discovery.

In February 2024, we launched the $1M Moonshot competition, challenging MIT and Harvard students, graduate students, postdocs, faculty, and alumni to compete for up to $1M in startup funding.

The software has been used in undergraduate and graduate classes in Boston, including one at MIT.

Rowan, a Boston, MA-based company building molecular design and simulation tools for scientists, raised $2.1M in Pre-Seed funding.

Two brothers and a friend founded the company to provide quantum mechanics–based services for novel drug discovery.

Molecular simulation is in a tough situation. Instead of relying on physical equations for our simulation, perhaps we can approximate them using black-box models.

The use of AI for predicting how molecules behave has made significant but still narrow progress compared to what is possible.

"Our focus is on creating tools that scientists will find indispensable," says Rowan co-founder Corin Wagen.

Rowan ... [is] positioning itself in the legacy of America's great applied R&D labs to foster real-world applications of scientific breakthroughs.

Experience quantum chemistry simplified with Rowan – the next-gen platform making molecular visualization accessible. Register now for 500 free credits!

Rowan is a software platform that makes it possible to run high-level quantum chemical calculations through a web interface.